Nuvation Bio Inc (NYSE:NUVB)
$ 6.6 +0.49 (+8.02%) Market Cap: 2.32 Bil Enterprise Value: 1.91 Bil PE Ratio: 0 PB Ratio: 7.17 GF Score: 33/100

Nuvation Bio Inc at TD Cowen Healthcare Conference Transcript

Mar 04, 2026 / 03:30PM GMT
Release Date Price: $4.74 (+8.72%)
Unidentified Analyst

Morning once again and welcome to the 46th biotech team, and it's a great pleasure to moderate the next fireside chat with Nation Bio.

With us today really needs no introduction, David Hong, co-founder, President and CEO, and Philippe Souva as well, Chief Financial Officer. Gentlemen, thanks for joining us. We appreciate it.

Questions & Answers

Unidentified Analyst

So maybe David and Phillipe for both of you, give us a little bit of a sense first of all, the market reaction. I mean this week has been kind of, bananas with everything that's going on. We've seen a lot of volatility in stocks. You printed a decent Q4. It was printed. Announced at JPMorgan. Any sense sort of what happened with the stock? What's your best sense and what was your main takeaway from your conference call?

David Hong
Nuvation Bio Inc - Co-founder, President and CEO

Yeah, so there, we think the stock reaction after the call was a little bit unusual. There, there's really no new news, as you said. We pre-announced our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot